Investing
Wednesday Afternoon's Top Analyst Upgrades and Downgrades: Coupang, Foot Locker, Gap, Stitch Fix and More
Published:
Markets bounced back with a vengeance on Wednesday, as the Nasdaq led the charge with a gain of over 2%. At the same time, oil prices pulled back from their 14-year highs in response to markets pushing higher. Investors are still weighing the ramifications of what trade sanctions with Russia might mean in the coming months, if not years.
24/7 Wall St. is reviewing some big analyst calls seen on Wednesday. We have included the latest call on each stock, as well as a recent trading history and the consensus targets among analysts. Note that analyst calls seen earlier in the day were on AMD, Dollar Tree, Kohl’s, Netflix, Palantir and many more.
Bumble Inc. (NASDAQ: BMBL): BMO Capital Markets upgraded the stock from Market Perform to Outperform with a $48 price target. The 52-week trading range is $15.92 to $76.49, and shares were trading near $24 Wednesday.
Coupang Inc. (NYSE: CPNG): UBS raised its Neutral rating to Buy. The 52-week trading range is $16.61 to $69.00, and shares were trading near $22 apiece on Wednesday.
Foot Locker Inc. (NYSE: FL): Argus’s downgrade was to Hold from Buy. Shares were trading near $30 on Wednesday. The 52-week range is $26.36 to $66.71.
Gap Inc. (NYSE: GPS): Daiwa Securities downgraded it to Underperform from Neutral and has a $13.75 price target. Shares were trading near $14 on Wednesday. The 52-week range is $13.12 to $37.63.
Match Group Inc. (NASDAQ: MTCH): BMO Capital Markets downgraded the shares to Market Perform from Outperform and has a $130 price target. Shares were trading near $96 on Wednesday. The 52-week range is $89.15 to $182.00.
Nektar Therapeutics (NASDAQ: NKTR): Oppenheimer’s upgrade was from Perform to Outperform with a $21 price target. The stock was trading near $11 on Wednesday, and the 52-week range is $9.31 to $23.50.
Paychex Inc. (NASDAQ: PAYX): BofA Securities lifted its Underperform rating to Neutral with a $125 price target. Shares were trading near $120. The 52-week range is $92.74 to $138.97.
Signify Health Inc. (NYSE: SGFY): UBS raised its $20 price target to $21 as it upgraded the stock to Buy from Neutral. The stock was trading around $17 on Wednesday, and the 52-week range is $11.11 to $31.91.
Stitch Fix Inc. (NASDAQ: SFIX): The Telsey Advisory downgrade to Market Perform from Outperform included a price target cut to $14 from $25. Truist also downgraded it, from Buy to Hold with a $12 price target. The 52-week trading range is $8.82 to $69.20, and shares were trading near $9 apiece Wednesday.
24/7 Wall St.Given recent geopolitical events, Goldman Sachs notes that vigilance at every level is now a huge priority to ensure cybersecurity and that six top companies will benefit from the increased spending across the industry.
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.